Loading…

The airway microbiome of persons with cystic fibrosis correlates with acquisition and microbiological outcomes of incident Stenotrophomonas maltophilia infection

Chronic infection with in persons with cystic fibrosis (pwCF) has been linked to an increased risk of pulmonary exacerbations and lung function decline. We sought to establish whether baseline sputum microbiome associates with risk of incident infection and persistence in pwCF. pwCF experiencing inc...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in microbiology 2024-04, Vol.15, p.1353145-1353145
Main Authors: Bowron, Lauren A, Acosta, Nicole, Thornton, Christina S, Carpentero, Jennifer, Waddell, Barbara-Jean M, Bharadwaj, Lalit, Ebbert, Kirsten, Castañeda-Mogollón, Daniel, Conly, John M, Rabin, Harvey R, Surette, Michael G, Parkins, Michael D
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c420t-833833499196f20356291b9d51fd6674b8cd92a4cc143bf3de92ac2d8e8854e43
container_end_page 1353145
container_issue
container_start_page 1353145
container_title Frontiers in microbiology
container_volume 15
creator Bowron, Lauren A
Acosta, Nicole
Thornton, Christina S
Carpentero, Jennifer
Waddell, Barbara-Jean M
Bharadwaj, Lalit
Ebbert, Kirsten
Castañeda-Mogollón, Daniel
Conly, John M
Rabin, Harvey R
Surette, Michael G
Parkins, Michael D
description Chronic infection with in persons with cystic fibrosis (pwCF) has been linked to an increased risk of pulmonary exacerbations and lung function decline. We sought to establish whether baseline sputum microbiome associates with risk of incident infection and persistence in pwCF. pwCF experiencing incident infections attending the Calgary Adult CF Clinic from 2010-2018 were compared with -negative sex, age (+/-2 years), and birth-cohort-matched controls. Infection outcomes were classified as persistent (when the pathogen was recovered in ≥50% of cultures in the subsequent year) or transient. We assessed microbial communities from prospectively biobanked sputum using V3-V4 16S ribosomal RNA (rRNA) gene sequencing, in the year preceding (Pre) (  = 57), at (At) (  = 22), and after (Post) (  = 31) incident infection. We verified relative abundance data using -specific qPCR and 16S rRNA-targeted qPCR to assess bioburden. Strains were typed using pulse-field gel electrophoresis. Twenty-five pwCF with incident (56% female, median 29 years, median FEV 61%) with 33 total episodes were compared with 56 uninfected pwCF controls. Demographics and clinical characteristics were similar between cohorts. Among those with incident infection, sputum communities did not cluster based on infection timeline (Pre, At, Post). Communities differed between the infection cohort and controls (  = 56) based on Shannon Diversity Index (SDI,  = 0.04) and clustered based on Aitchison distance (PERMANOVA,  = 0.01) prior to infection. At the time of incident isolation, communities did not differ in SDI but clustered based on Aitchison distance (PERMANOVA,  = 0.03) in those that ultimately developed persistent infection versus those that were transient. abundance within sputum was increased in samples from patients (Pre) relative to controls, measuring both relative (  = 0.004) and absolute (  = 0.001). Furthermore, abundance was increased in sputum at incident infection in those who ultimately developed persistent infection relative to those with transient infection, measured relatively (  = 0.04) or absolute (  = 0.04), respectively. Microbial community composition of CF sputum associates with infection acquisition as well as infection outcome. Our study suggests sputum microbiome may serve as a surrogate for identifying infection risk and persistence risk.
doi_str_mv 10.3389/fmicb.2024.1353145
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_dd0848fe9ed644279f0ecfb6c25b774c</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_dd0848fe9ed644279f0ecfb6c25b774c</doaj_id><sourcerecordid>3049718017</sourcerecordid><originalsourceid>FETCH-LOGICAL-c420t-833833499196f20356291b9d51fd6674b8cd92a4cc143bf3de92ac2d8e8854e43</originalsourceid><addsrcrecordid>eNpVkt9uFCEUxidGY5vaF_DCcOnNrvybGbgyprHapIkX1sQ7wsBhl4YZtsDY7OP4pjLdddNyARzOd37Aydc07wleMybkJzd6M6wppnxNWMsIb18156Tr-Iph-vv1s_1Zc5nzPa6DY1rnt80ZE53ErCfnzd-7LSDt06Peo0pMcfBxBBQd2kHKccro0ZctMvtcvEHODylmn5GJKUHQBY55bR5mn33xcUJ6sidUiBtvdEBxLqZy8wL2k_EWpoJ-FphiSXG3jWOcdEajDqVGPnhdVQ7MwnvXvHE6ZLg8rhfNr-uvd1ffV7c_vt1cfbldGU5xWYnaFca4lER2jmLWdlSSQdqWONt1PR-EsZJqbgzhbHDMQo0MtQKEaDlwdtHcHLg26nu1S37Uaa-i9urpIKaN0qk2IYCyFgsuHEiwHee0lw6DcUNnaDv0PTeV9fnA2s3DCNbU3yYdXkBfZia_VZv4RxGCW4lpXwkfj4QUH2bIRY0-GwhBTxDnrBjmsicCk0VKD9La8pwTuNM9BKvFK-rJK2rxijp6pRZ9eP7CU8l_Z7B_xjfBbA</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3049718017</pqid></control><display><type>article</type><title>The airway microbiome of persons with cystic fibrosis correlates with acquisition and microbiological outcomes of incident Stenotrophomonas maltophilia infection</title><source>PubMed Central</source><creator>Bowron, Lauren A ; Acosta, Nicole ; Thornton, Christina S ; Carpentero, Jennifer ; Waddell, Barbara-Jean M ; Bharadwaj, Lalit ; Ebbert, Kirsten ; Castañeda-Mogollón, Daniel ; Conly, John M ; Rabin, Harvey R ; Surette, Michael G ; Parkins, Michael D</creator><creatorcontrib>Bowron, Lauren A ; Acosta, Nicole ; Thornton, Christina S ; Carpentero, Jennifer ; Waddell, Barbara-Jean M ; Bharadwaj, Lalit ; Ebbert, Kirsten ; Castañeda-Mogollón, Daniel ; Conly, John M ; Rabin, Harvey R ; Surette, Michael G ; Parkins, Michael D</creatorcontrib><description>Chronic infection with in persons with cystic fibrosis (pwCF) has been linked to an increased risk of pulmonary exacerbations and lung function decline. We sought to establish whether baseline sputum microbiome associates with risk of incident infection and persistence in pwCF. pwCF experiencing incident infections attending the Calgary Adult CF Clinic from 2010-2018 were compared with -negative sex, age (+/-2 years), and birth-cohort-matched controls. Infection outcomes were classified as persistent (when the pathogen was recovered in ≥50% of cultures in the subsequent year) or transient. We assessed microbial communities from prospectively biobanked sputum using V3-V4 16S ribosomal RNA (rRNA) gene sequencing, in the year preceding (Pre) (  = 57), at (At) (  = 22), and after (Post) (  = 31) incident infection. We verified relative abundance data using -specific qPCR and 16S rRNA-targeted qPCR to assess bioburden. Strains were typed using pulse-field gel electrophoresis. Twenty-five pwCF with incident (56% female, median 29 years, median FEV 61%) with 33 total episodes were compared with 56 uninfected pwCF controls. Demographics and clinical characteristics were similar between cohorts. Among those with incident infection, sputum communities did not cluster based on infection timeline (Pre, At, Post). Communities differed between the infection cohort and controls (  = 56) based on Shannon Diversity Index (SDI,  = 0.04) and clustered based on Aitchison distance (PERMANOVA,  = 0.01) prior to infection. At the time of incident isolation, communities did not differ in SDI but clustered based on Aitchison distance (PERMANOVA,  = 0.03) in those that ultimately developed persistent infection versus those that were transient. abundance within sputum was increased in samples from patients (Pre) relative to controls, measuring both relative (  = 0.004) and absolute (  = 0.001). Furthermore, abundance was increased in sputum at incident infection in those who ultimately developed persistent infection relative to those with transient infection, measured relatively (  = 0.04) or absolute (  = 0.04), respectively. Microbial community composition of CF sputum associates with infection acquisition as well as infection outcome. Our study suggests sputum microbiome may serve as a surrogate for identifying infection risk and persistence risk.</description><identifier>ISSN: 1664-302X</identifier><identifier>EISSN: 1664-302X</identifier><identifier>DOI: 10.3389/fmicb.2024.1353145</identifier><identifier>PMID: 38690371</identifier><language>eng</language><publisher>Switzerland: Frontiers Media S.A</publisher><subject>bronchiectasis ; cystic fibrosis ; emerging infections ; incident ; Microbiology ; microbiome ; Stenotrophomonas maltophilia</subject><ispartof>Frontiers in microbiology, 2024-04, Vol.15, p.1353145-1353145</ispartof><rights>Copyright © 2024 Bowron, Acosta, Thornton, Carpentero, Waddell, Bharadwaj, Ebbert, Castañeda-Mogollón, Conly, Rabin, Surette and Parkins.</rights><rights>Copyright © 2024 Bowron, Acosta, Thornton, Carpentero, Waddell, Bharadwaj, Ebbert, Castañeda-Mogollón, Conly, Rabin, Surette and Parkins. 2024 Bowron, Acosta, Thornton, Carpentero, Waddell, Bharadwaj, Ebbert, Castañeda-Mogollón, Conly, Rabin, Surette and Parkins</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c420t-833833499196f20356291b9d51fd6674b8cd92a4cc143bf3de92ac2d8e8854e43</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11059027/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11059027/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38690371$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bowron, Lauren A</creatorcontrib><creatorcontrib>Acosta, Nicole</creatorcontrib><creatorcontrib>Thornton, Christina S</creatorcontrib><creatorcontrib>Carpentero, Jennifer</creatorcontrib><creatorcontrib>Waddell, Barbara-Jean M</creatorcontrib><creatorcontrib>Bharadwaj, Lalit</creatorcontrib><creatorcontrib>Ebbert, Kirsten</creatorcontrib><creatorcontrib>Castañeda-Mogollón, Daniel</creatorcontrib><creatorcontrib>Conly, John M</creatorcontrib><creatorcontrib>Rabin, Harvey R</creatorcontrib><creatorcontrib>Surette, Michael G</creatorcontrib><creatorcontrib>Parkins, Michael D</creatorcontrib><title>The airway microbiome of persons with cystic fibrosis correlates with acquisition and microbiological outcomes of incident Stenotrophomonas maltophilia infection</title><title>Frontiers in microbiology</title><addtitle>Front Microbiol</addtitle><description>Chronic infection with in persons with cystic fibrosis (pwCF) has been linked to an increased risk of pulmonary exacerbations and lung function decline. We sought to establish whether baseline sputum microbiome associates with risk of incident infection and persistence in pwCF. pwCF experiencing incident infections attending the Calgary Adult CF Clinic from 2010-2018 were compared with -negative sex, age (+/-2 years), and birth-cohort-matched controls. Infection outcomes were classified as persistent (when the pathogen was recovered in ≥50% of cultures in the subsequent year) or transient. We assessed microbial communities from prospectively biobanked sputum using V3-V4 16S ribosomal RNA (rRNA) gene sequencing, in the year preceding (Pre) (  = 57), at (At) (  = 22), and after (Post) (  = 31) incident infection. We verified relative abundance data using -specific qPCR and 16S rRNA-targeted qPCR to assess bioburden. Strains were typed using pulse-field gel electrophoresis. Twenty-five pwCF with incident (56% female, median 29 years, median FEV 61%) with 33 total episodes were compared with 56 uninfected pwCF controls. Demographics and clinical characteristics were similar between cohorts. Among those with incident infection, sputum communities did not cluster based on infection timeline (Pre, At, Post). Communities differed between the infection cohort and controls (  = 56) based on Shannon Diversity Index (SDI,  = 0.04) and clustered based on Aitchison distance (PERMANOVA,  = 0.01) prior to infection. At the time of incident isolation, communities did not differ in SDI but clustered based on Aitchison distance (PERMANOVA,  = 0.03) in those that ultimately developed persistent infection versus those that were transient. abundance within sputum was increased in samples from patients (Pre) relative to controls, measuring both relative (  = 0.004) and absolute (  = 0.001). Furthermore, abundance was increased in sputum at incident infection in those who ultimately developed persistent infection relative to those with transient infection, measured relatively (  = 0.04) or absolute (  = 0.04), respectively. Microbial community composition of CF sputum associates with infection acquisition as well as infection outcome. Our study suggests sputum microbiome may serve as a surrogate for identifying infection risk and persistence risk.</description><subject>bronchiectasis</subject><subject>cystic fibrosis</subject><subject>emerging infections</subject><subject>incident</subject><subject>Microbiology</subject><subject>microbiome</subject><subject>Stenotrophomonas maltophilia</subject><issn>1664-302X</issn><issn>1664-302X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNpVkt9uFCEUxidGY5vaF_DCcOnNrvybGbgyprHapIkX1sQ7wsBhl4YZtsDY7OP4pjLdddNyARzOd37Aydc07wleMybkJzd6M6wppnxNWMsIb18156Tr-Iph-vv1s_1Zc5nzPa6DY1rnt80ZE53ErCfnzd-7LSDt06Peo0pMcfBxBBQd2kHKccro0ZctMvtcvEHODylmn5GJKUHQBY55bR5mn33xcUJ6sidUiBtvdEBxLqZy8wL2k_EWpoJ-FphiSXG3jWOcdEajDqVGPnhdVQ7MwnvXvHE6ZLg8rhfNr-uvd1ffV7c_vt1cfbldGU5xWYnaFca4lER2jmLWdlSSQdqWONt1PR-EsZJqbgzhbHDMQo0MtQKEaDlwdtHcHLg26nu1S37Uaa-i9urpIKaN0qk2IYCyFgsuHEiwHee0lw6DcUNnaDv0PTeV9fnA2s3DCNbU3yYdXkBfZia_VZv4RxGCW4lpXwkfj4QUH2bIRY0-GwhBTxDnrBjmsicCk0VKD9La8pwTuNM9BKvFK-rJK2rxijp6pRZ9eP7CU8l_Z7B_xjfBbA</recordid><startdate>20240416</startdate><enddate>20240416</enddate><creator>Bowron, Lauren A</creator><creator>Acosta, Nicole</creator><creator>Thornton, Christina S</creator><creator>Carpentero, Jennifer</creator><creator>Waddell, Barbara-Jean M</creator><creator>Bharadwaj, Lalit</creator><creator>Ebbert, Kirsten</creator><creator>Castañeda-Mogollón, Daniel</creator><creator>Conly, John M</creator><creator>Rabin, Harvey R</creator><creator>Surette, Michael G</creator><creator>Parkins, Michael D</creator><general>Frontiers Media S.A</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20240416</creationdate><title>The airway microbiome of persons with cystic fibrosis correlates with acquisition and microbiological outcomes of incident Stenotrophomonas maltophilia infection</title><author>Bowron, Lauren A ; Acosta, Nicole ; Thornton, Christina S ; Carpentero, Jennifer ; Waddell, Barbara-Jean M ; Bharadwaj, Lalit ; Ebbert, Kirsten ; Castañeda-Mogollón, Daniel ; Conly, John M ; Rabin, Harvey R ; Surette, Michael G ; Parkins, Michael D</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c420t-833833499196f20356291b9d51fd6674b8cd92a4cc143bf3de92ac2d8e8854e43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>bronchiectasis</topic><topic>cystic fibrosis</topic><topic>emerging infections</topic><topic>incident</topic><topic>Microbiology</topic><topic>microbiome</topic><topic>Stenotrophomonas maltophilia</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bowron, Lauren A</creatorcontrib><creatorcontrib>Acosta, Nicole</creatorcontrib><creatorcontrib>Thornton, Christina S</creatorcontrib><creatorcontrib>Carpentero, Jennifer</creatorcontrib><creatorcontrib>Waddell, Barbara-Jean M</creatorcontrib><creatorcontrib>Bharadwaj, Lalit</creatorcontrib><creatorcontrib>Ebbert, Kirsten</creatorcontrib><creatorcontrib>Castañeda-Mogollón, Daniel</creatorcontrib><creatorcontrib>Conly, John M</creatorcontrib><creatorcontrib>Rabin, Harvey R</creatorcontrib><creatorcontrib>Surette, Michael G</creatorcontrib><creatorcontrib>Parkins, Michael D</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Directory of Open Access Journals</collection><jtitle>Frontiers in microbiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bowron, Lauren A</au><au>Acosta, Nicole</au><au>Thornton, Christina S</au><au>Carpentero, Jennifer</au><au>Waddell, Barbara-Jean M</au><au>Bharadwaj, Lalit</au><au>Ebbert, Kirsten</au><au>Castañeda-Mogollón, Daniel</au><au>Conly, John M</au><au>Rabin, Harvey R</au><au>Surette, Michael G</au><au>Parkins, Michael D</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The airway microbiome of persons with cystic fibrosis correlates with acquisition and microbiological outcomes of incident Stenotrophomonas maltophilia infection</atitle><jtitle>Frontiers in microbiology</jtitle><addtitle>Front Microbiol</addtitle><date>2024-04-16</date><risdate>2024</risdate><volume>15</volume><spage>1353145</spage><epage>1353145</epage><pages>1353145-1353145</pages><issn>1664-302X</issn><eissn>1664-302X</eissn><abstract>Chronic infection with in persons with cystic fibrosis (pwCF) has been linked to an increased risk of pulmonary exacerbations and lung function decline. We sought to establish whether baseline sputum microbiome associates with risk of incident infection and persistence in pwCF. pwCF experiencing incident infections attending the Calgary Adult CF Clinic from 2010-2018 were compared with -negative sex, age (+/-2 years), and birth-cohort-matched controls. Infection outcomes were classified as persistent (when the pathogen was recovered in ≥50% of cultures in the subsequent year) or transient. We assessed microbial communities from prospectively biobanked sputum using V3-V4 16S ribosomal RNA (rRNA) gene sequencing, in the year preceding (Pre) (  = 57), at (At) (  = 22), and after (Post) (  = 31) incident infection. We verified relative abundance data using -specific qPCR and 16S rRNA-targeted qPCR to assess bioburden. Strains were typed using pulse-field gel electrophoresis. Twenty-five pwCF with incident (56% female, median 29 years, median FEV 61%) with 33 total episodes were compared with 56 uninfected pwCF controls. Demographics and clinical characteristics were similar between cohorts. Among those with incident infection, sputum communities did not cluster based on infection timeline (Pre, At, Post). Communities differed between the infection cohort and controls (  = 56) based on Shannon Diversity Index (SDI,  = 0.04) and clustered based on Aitchison distance (PERMANOVA,  = 0.01) prior to infection. At the time of incident isolation, communities did not differ in SDI but clustered based on Aitchison distance (PERMANOVA,  = 0.03) in those that ultimately developed persistent infection versus those that were transient. abundance within sputum was increased in samples from patients (Pre) relative to controls, measuring both relative (  = 0.004) and absolute (  = 0.001). Furthermore, abundance was increased in sputum at incident infection in those who ultimately developed persistent infection relative to those with transient infection, measured relatively (  = 0.04) or absolute (  = 0.04), respectively. Microbial community composition of CF sputum associates with infection acquisition as well as infection outcome. Our study suggests sputum microbiome may serve as a surrogate for identifying infection risk and persistence risk.</abstract><cop>Switzerland</cop><pub>Frontiers Media S.A</pub><pmid>38690371</pmid><doi>10.3389/fmicb.2024.1353145</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1664-302X
ispartof Frontiers in microbiology, 2024-04, Vol.15, p.1353145-1353145
issn 1664-302X
1664-302X
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_dd0848fe9ed644279f0ecfb6c25b774c
source PubMed Central
subjects bronchiectasis
cystic fibrosis
emerging infections
incident
Microbiology
microbiome
Stenotrophomonas maltophilia
title The airway microbiome of persons with cystic fibrosis correlates with acquisition and microbiological outcomes of incident Stenotrophomonas maltophilia infection
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T20%3A05%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20airway%20microbiome%20of%20persons%20with%20cystic%20fibrosis%20correlates%20with%20acquisition%20and%20microbiological%20outcomes%20of%20incident%20Stenotrophomonas%20maltophilia%20infection&rft.jtitle=Frontiers%20in%20microbiology&rft.au=Bowron,%20Lauren%20A&rft.date=2024-04-16&rft.volume=15&rft.spage=1353145&rft.epage=1353145&rft.pages=1353145-1353145&rft.issn=1664-302X&rft.eissn=1664-302X&rft_id=info:doi/10.3389/fmicb.2024.1353145&rft_dat=%3Cproquest_doaj_%3E3049718017%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c420t-833833499196f20356291b9d51fd6674b8cd92a4cc143bf3de92ac2d8e8854e43%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3049718017&rft_id=info:pmid/38690371&rfr_iscdi=true